BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15674397)

  • 1. Variability in infectivity of primary cell cultures of human brain tumors with HSV-1 amplicon vectors.
    Rueger MA; Winkeler A; Miletic H; Kaestle C; Richter R; Schneider G; Hilker R; Heneka MT; Ernestus RI; Hampl JA; Fraefel C; Jacobs AH
    Gene Ther; 2005 Apr; 12(7):588-96. PubMed ID: 15674397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.
    Zibert A; Thomassen A; Müller L; Nguyen L; Glouchkova L; Fraefel C; Roskrow M; Meisel R; Dilloo D
    Gene Ther; 2005 Dec; 12(23):1707-17. PubMed ID: 16034459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment.
    Hoffmann D; Wildner O
    Cancer Gene Ther; 2007 Jul; 14(7):627-39. PubMed ID: 17479104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging herpes simplex virus type 1 amplicon vector-mediated gene expression in human glioma spheroids.
    Kaestle C; Winkeler A; Richter R; Sauer H; Hescheler J; Fraefel C; Wartenberg M; Jacobs AH
    Mol Imaging; 2011 Jun; 10(3):197-205. PubMed ID: 21443839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
    Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
    Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells.
    Ho IA; Chan KY; Miao L; Shim WS; Guo CM; Cheang P; Hui KM; Lam PY
    Cancer Gene Ther; 2008 Sep; 15(9):553-62. PubMed ID: 18535622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons.
    Müller L; Saydam O; Saeki Y; Heid I; Fraefel C
    J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation.
    Saydam O; Saydam N; Glauser DL; Pruschy M; Dinh-Van V; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
    Gene Ther; 2007 Aug; 14(15):1143-51. PubMed ID: 17495946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo.
    Saydam O; Glauser DL; Heid I; Turkeri G; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
    Mol Ther; 2005 Nov; 12(5):803-12. PubMed ID: 16112910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting human glioma cells using HSV-1 amplicon peptide display vector.
    Ho IA; Miao L; Sia KC; Wang GY; Hui KM; Lam PY
    Gene Ther; 2010 Feb; 17(2):250-60. PubMed ID: 19812609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.
    Krummenacher C; Baribaud F; Ponce de Leon M; Baribaud I; Whitbeck JC; Xu R; Cohen GH; Eisenberg RJ
    Virology; 2004 May; 322(2):286-99. PubMed ID: 15110526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of HSV mass distribution in a rodent brain tumor model.
    Schellingerhout D; Rainov NG; Breakefield XO; Weissleder R
    Gene Ther; 2000 Oct; 7(19):1648-55. PubMed ID: 11083473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
    Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
    Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient and non-toxic gene transfer to cardiomyocytes using novel generation amplicon vectors derived from HSV-1.
    Ferrera R; Cuchet D; Zaupa C; Revol-Guyot V; Ovize M; Epstein AL
    J Mol Cell Cardiol; 2005 Jan; 38(1):219-23. PubMed ID: 15623439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.
    Kambara H; Okano H; Chiocca EA; Saeki Y
    Cancer Res; 2005 Apr; 65(7):2832-9. PubMed ID: 15805284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of entry receptor nectin-1 of herpes simplex virus 1 and/or herpes simplex virus 2 in normal and neoplastic human nervous system tissues.
    Guzman G; Oh S; Shukla D; Engelhard HH; Valyi-Nagy T
    Acta Virol; 2006; 50(1):59-66. PubMed ID: 16599187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between expression and genome transfer titering of HSV amplicon vectors: recommendation for standardized enumeration.
    Bowers WJ; Howard DF; Federoff HJ
    Mol Ther; 2000 Mar; 1(3):294-9. PubMed ID: 10933945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a novel foreign gene delivery system combining an HSV amplicon with an attenuated replication-competent virus, HSV-1 HF10.
    Zhang L; Daikoku T; Ohtake K; Ohtsuka J; Nawa A; Kudoh A; Iwahori S; Isomura H; Nishiyama Y; Tsurumi T
    J Virol Methods; 2006 Nov; 137(2):177-83. PubMed ID: 16854473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting HSV amplicon vectors.
    Grandi P; Spear M; Breakefield XO; Wang S
    Methods; 2004 Jun; 33(2):179-86. PubMed ID: 15121173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.